Login / Signup

Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohort.

Stephanie T JüngerMartin MynarekInken WohlersEvelyn DörnerAnja Zur MühlenNatalia Velez-CharKatja von HoffStefan RutkowskiMonika Warmuth-MetzRolf-Dieter KortmannBeate TimmermannSven RahmannLudger Klein-HitpassAndre O von BuerenTorsten Pietsch
Published in: Acta neuropathologica communications (2019)
The integration of defined clinical, histological and genetic parameters led to an improved risk-stratification model for posterior fossa ependymoma of childhood. After validation in independent cohorts this model may provide the basis for risk-adapted treatment of children with ependymomas of the posterior fossa.
Keyphrases
  • genome wide
  • young adults
  • clinical trial
  • randomized controlled trial
  • study protocol
  • phase iii
  • gene expression
  • dna methylation
  • childhood cancer
  • phase ii
  • combination therapy